Bladder cancer biomarker proteins

Jérôme Garin; Christophe Masselon; Antonia Vlahou; Bruno Domon; Elodie Duriez; Francois Radvanyi; Yves Allory; Nuria Marquez Cid; Magali Mirari Court; Riera Malatas; Aurélie Kamoun; Manousos Makrydakis; Ieronimos Zoidakis

Bladder cancer biomarker proteins

Jérôme Garin (Inventor)
, Christophe Masselon (Inventor)
, Antonia Vlahou (Inventor)
, Bruno Domon (Inventor)
, Elodie Duriez (Inventor)
, Francois Radvanyi (Inventor)
, Yves Allory (Inventor)
, Nuria Marquez Cid (Inventor)
, Magali Mirari Court (Inventor)
, Riera Malatas (Inventor)
, Aurélie Kamoun (Inventor)
, Manousos Makrydakis (Inventor)
, Ieronimos Zoidakis (Inventor)

Luxembourg Institute of Health

Research output: Patent

Abstract

The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.

Original language	English
IPC	WO 2017/109171
Publication status	Published - 29 Jun 2017

Cite this

@misc{4a845ce58467433bb3076c3da990b48a,

title = "Bladder cancer biomarker proteins",

abstract = "The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.",

author = "J{\'e}r{\^o}me Garin and Christophe Masselon and Antonia Vlahou and Bruno Domon and Elodie Duriez and Francois Radvanyi and Yves Allory and \{Marquez Cid\}, Nuria and \{Mirari Court\}, Magali and Riera Malatas and Aur{\'e}lie Kamoun and Manousos Makrydakis and Ieronimos Zoidakis",

year = "2017",

month = jun,

day = "29",

language = "English",

type = "Patent",

note = "WO 2017/109171",

}

TY - PAT

T1 - Bladder cancer biomarker proteins

AU - Garin, Jérôme

AU - Masselon, Christophe

AU - Vlahou, Antonia

AU - Domon, Bruno

AU - Duriez, Elodie

AU - Radvanyi, Francois

AU - Allory, Yves

AU - Marquez Cid, Nuria

AU - Mirari Court, Magali

AU - Malatas, Riera

AU - Kamoun, Aurélie

AU - Makrydakis, Manousos

AU - Zoidakis, Ieronimos

PY - 2017/6/29

Y1 - 2017/6/29

N2 - The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.

AB - The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.

M3 - Patent

ER -

Bladder cancer biomarker proteins

Abstract

Fingerprint

Cite this